NORTHWEST BIOTHERAPEUTICS INC's ticker is and the CUSIP is 66737P950. A total of 2 filers reported holding NORTHWEST BIOTHERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $47,000 | -60.5% | 813 | 0.0% | 0.00% | -66.7% |
Q1 2016 | $119,000 | -68.1% | 813 | -30.2% | 0.01% | -71.4% |
Q4 2015 | $373,000 | -90.1% | 1,165 | -80.7% | 0.02% | -86.5% |
Q3 2015 | $3,776,000 | -44.6% | 6,042 | -11.9% | 0.16% | -37.3% |
Q2 2015 | $6,814,000 | +160.5% | 6,862 | +93.2% | 0.25% | +128.4% |
Q1 2015 | $2,616,000 | +44.1% | 3,552 | +4.7% | 0.11% | +91.2% |
Q4 2014 | $1,816,000 | +7.6% | 3,394 | +1.2% | 0.06% | -12.3% |
Q3 2014 | $1,687,000 | +36.6% | 3,353 | +82.1% | 0.06% | +22.6% |
Q2 2014 | $1,235,000 | +96.7% | 1,841 | +112.1% | 0.05% | +51.4% |
Q1 2014 | $628,000 | -8.1% | 868 | -52.1% | 0.04% | -20.5% |
Q4 2013 | $683,000 | – | 1,812 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 3,353 | $1,687,000 | 0.06% |
Citadel Advisors | 65,100 | $327,000 | 0.00% |